Zeidan AM - Search Results

1

Why do we not have more drugs approved for MDS? A critical viewpoint on novel drug development in MDS.

Frumm SM, Shimony S, Stone RM, DeAngelo DJ, Bewersdorf JP, Zeidan AM, Stahl M. Frumm SM, et al. Among authors: zeidan am. Blood Rev. 2023 Jul;60:101056. doi: 10.1016/j.blre.2023.101056. Epub 2023 Feb 12. Blood Rev. 2023. PMID: 36805300 Review.

2

The evolving field of prognostication and risk stratification in MDS: Recent developments and future directions.

Lee EJ, Podoltsev N, Gore SD, Zeidan AM. Lee EJ, et al. Among authors: zeidan am. Blood Rev. 2016 Jan;30(1):1-10. doi: 10.1016/j.blre.2015.06.004. Epub 2015 Jun 19. Blood Rev. 2016. PMID: 26119927 Review.

3

Clinical response to ruxolitinib in CSF3R T618-mutated chronic neutrophilic leukemia.

Stahl M, Xu ML, Steensma DP, Rampal R, Much M, Zeidan AM. Stahl M, et al. Among authors: zeidan am. Ann Hematol. 2016 Jun;95(7):1197-200. doi: 10.1007/s00277-016-2664-4. Epub 2016 Apr 11. Ann Hematol. 2016. PMID: 27068405 Free PMC article. No abstract available.

4

Chronic myelomoncytic leukemia: Are we finally solving the identity crisis?

Nazha A, Prebet T, Gore S, Zeidan AM. Nazha A, et al. Among authors: zeidan am. Blood Rev. 2016 Sep;30(5):381-8. doi: 10.1016/j.blre.2016.04.006. Epub 2016 Apr 25. Blood Rev. 2016. PMID: 27162201 Review.

5

Single agent blinatumumab as frontline therapy for an 85-year-old patient with B cell precursor acute lymphoblastic leukemia.

Kim TK, Xu ML, Podoltsev NA, Prebet T, Barbarotta L, Amin K, Kasberg S, Roche K, Stahl M, Gore SD, Zeidan AM. Kim TK, et al. Among authors: zeidan am. Ann Hematol. 2016 Oct;95(11):1895-8. doi: 10.1007/s00277-016-2761-4. Epub 2016 Jul 29. Ann Hematol. 2016. PMID: 27468851 Free PMC article. No abstract available.

6

Emerging biological therapies for the treatment of myelodysplastic syndromes.

Zeidan AM, Stahl M, Komrokji R. Zeidan AM, et al. Expert Opin Emerg Drugs. 2016 Sep;21(3):283-300. doi: 10.1080/14728214.2016.1220534. Epub 2016 Aug 19. Expert Opin Emerg Drugs. 2016. PMID: 27486848 Review.

7

Epigenetics in Cancer: A Hematological Perspective.

Stahl M, Kohrman N, Gore SD, Kim TK, Zeidan AM, Prebet T. Stahl M, et al. Among authors: zeidan am. PLoS Genet. 2016 Oct 10;12(10):e1006193. doi: 10.1371/journal.pgen.1006193. eCollection 2016 Oct. PLoS Genet. 2016. PMID: 27723796 Free PMC article. Review.

8

Selecting initial treatment of acute myeloid leukaemia in older adults.

Podoltsev NA, Stahl M, Zeidan AM, Gore SD. Podoltsev NA, et al. Among authors: zeidan am. Blood Rev. 2017 Mar;31(2):43-62. doi: 10.1016/j.blre.2016.09.005. Epub 2016 Oct 8. Blood Rev. 2017. PMID: 27745715 Review.

9

Update on acute myeloid leukemia stem cells: New discoveries and therapeutic opportunities.

Stahl M, Kim TK, Zeidan AM. Stahl M, et al. Among authors: zeidan am. World J Stem Cells. 2016 Oct 26;8(10):316-331. doi: 10.4252/wjsc.v8.i10.316. World J Stem Cells. 2016. PMID: 27822339 Free PMC article. Review.

10

Wide variations in blood product transfusion practices among providers who care for patients with acute leukemia in the United States.

Pine AB, Lee EJ, Sekeres M, Steensma DP, Zelterman D, Prebet T, DeZern A, Komrokji R, Litzow M, Luger S, Stone R, Erba HP, Garcia-Manero G, Lee AI, Podoltsev NA, Barbarotta L, Kasberg S, Hendrickson JE, Gore SD, Zeidan AM. Pine AB, et al. Among authors: zeidan am. Transfusion. 2017 Feb;57(2):289-295. doi: 10.1111/trf.13934. Epub 2016 Nov 22. Transfusion. 2017. PMID: 27878822 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

327 results

Search Page

Filters